RxDoctor Payments Data

William Polley, MD

Internal Medicine · Fairlawn, OHNPI 1588683650

Payments from drug & device makers

$623in general payments, 2019–2025

Across 41 payments — averaging $15.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$358
  • Lilly USA, LLC$127
  • Astellas Pharma US Inc$64
  • Pfizer$24
  • AbbVie$23
  • Esperion Therapeutics, Inc.$14
  • plus $13 from 1 others

What the payments were for

  • Food & beverage$57392%
  • Education$508%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$623 in reported general payments places this provider in the 65th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$26,206
Medicare patients
47
Services billed
224

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RybelsusSemaglutide29$46,641
OzempicSemaglutide31$35,843
Trelegy ElliptaFluticasone/Umeclidin/Vilanter40$31,685
EliquisApixaban37$26,122
FarxigaDapagliflozin Propanediol38$22,009
TradjentaLinagliptin30$14,289
JanuviaSitagliptin Phosphate25$12,605
XareltoRivaroxaban11$9,034
MyrbetriqMirabegron15$8,437
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen104$4,275
Incruse ElliptaUmeclidinium Bromide11$3,672
Metoprolol Succinate162$2,742
Omeprazole97$2,518
Atorvastatin Calcium202$2,270
Albuterol Sulfate HfaAlbuterol Sulfate66$1,671

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$358$82,48460 claims
PfizerEliquis, Paxlovid$24$27,49448 claims
Johnson & JohnsonXarelto$13$9,03411 claims
Astellas Pharma US IncMyrbetriq$64$8,43715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in Fairlawn

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →